Literature DB >> 8866582

Recycling of hard-core smokers with nicotine nasal spray.

P Tønnesen1, K Mikkelsen, J Nørregaard, S Jørgensen.   

Abstract

The primary aim of this smoking cessation study was to evaluate the effect of long-term treatment with nicotine nasal spray in a group of hard-core smokers. A further aim was to compare the effect of ad libitum with fixed dosage of nasal nicotine spray. Eighty nine smokers, failures from two earlier studies with nicotine patches, were enrolled in an open smoking cessation study with nicotine nasal sprays, to be used ad libitum (n=45) or on a fixed schedule of 1 mg x h-1 during the day (n= 44). Carbon monoxide-verified continuous abstinence from smoking beyond Week 2, was 39% at 3 weeks, 12% at 3 months, 10% at 6 months and 6% after 1 yr, with no significant difference in success rate between ad libitum and fixed dosing. Mean daily nicotine dose was 15-16 mg during the first 3 months (range 2-65 mg). Tolerance to local irritating side-effects of nicotine developed during the first weeks of use. Although short-term outcome was promising, the long-term success rate in this group of hardcore smokers was low. Other recycling set-ups are warranted, which might include more aggressive nicotine dosing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866582     DOI: 10.1183/09031936.96.09081619

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Predictors of early versus late smoking abstinence within a 24-month disease management program.

Authors:  Lisa Sanderson Cox; Jo A Wick; Niaman Nazir; A Paula Cupertino; Laura M Mussulman; Jasjit S Ahluwalia; Edward F Ellerbeck
Journal:  Nicotine Tob Res       Date:  2011-01-13       Impact factor: 4.244

Review 2.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

3.  Effectiveness of Switching Smoking-Cessation Medications Following Relapse.

Authors:  Bryan W Heckman; K Michael Cummings; Karin A Kasza; Ron Borland; Jessica L Burris; Geoffrey T Fong; Ann McNeill; Matthew J Carpenter
Journal:  Am J Prev Med       Date:  2017-03-20       Impact factor: 5.043

4.  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Authors:  Nicola Lindson; Samantha C Chepkin; Weiyu Ye; Thomas R Fanshawe; Chris Bullen; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-04-18

Review 5.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Design and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary care.

Authors:  Lisa Sanderson Cox; Ana-Paula Cupertino; Laura M Mussulman; Niaman Nazir; K Allen Greiner; Jonathan D Mahnken; Jasjit S Ahluwalia; Edward F Ellerbeck
Journal:  Prev Med       Date:  2008-05-03       Impact factor: 4.018

7.  Effect of varying levels of disease management on smoking cessation: a randomized trial.

Authors:  Edward F Ellerbeck; Jonathan D Mahnken; A Paula Cupertino; Lisa Sanderson Cox; K Allen Greiner; Laura M Mussulman; Niaman Nazir; Theresa I Shireman; Kenneth Resnicow; Jasjit S Ahluwalia
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

8.  Reaching out, inviting back: using Interactive voice response (IVR) technology to recycle relapsed smokers back to Quitline treatment--a randomized controlled trial.

Authors:  Beatriz H Carlini; Anna M McDaniel; Michael T Weaver; Ross M Kauffman; Barbara Cerutti; Renée M Stratton; Susan M Zbikowski
Journal:  BMC Public Health       Date:  2012-07-06       Impact factor: 3.295

Review 9.  Nicotine replacement therapy versus control for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Samantha C Chepkin; Weiyu Ye; Chris Bullen; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

10.  Use of nicotine substitute prescribed at hourly plus ab libitum intake or ad libitum for heavy smokers willing to quit: a randomized controlled trial.

Authors:  Laurent Rey; Paul Vaucher; Françoise Secretan; Jean-Pierre Zellweger; Patrick Bodenmann
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.